Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer
- Authors
- Kim, Jung Lim; Kim, Bo Ram; Kim, Dae Yeong; Jeong, Yoon A.; Jeong, So yeon; Na, Yoo Jin; Park, Seong Hye; Yun, Hye Kyeong; Jo, Min Jee; Kim, Bu Gyeom; Kim, Han Do; Kim, Dae Hyun; Oh, Sang Cheul; Lee, Sun Il; Lee, Dae Hee
- Issue Date
- May-2019
- Publisher
- MDPI
- Keywords
- cannabidiol; TNF-related apoptosis-inducing ligand; death receptor 5; endoplasmic reticulum stress
- Citation
- CANCERS, v.11, no.5
- Indexed
- SCIE
SCOPUS
- Journal Title
- CANCERS
- Volume
- 11
- Number
- 5
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/2125
- DOI
- 10.3390/cancers11050642
- ISSN
- 2072-6694
2072-6694
- Abstract
- Cannabidiol, a major non-psychotomimetic compound derived from Cannabis sativa, is a potential therapeutic agent for a variety of diseases such as inflammatory diseases, chronic neurodegenerative diseases, and cancers. Here, we found that the combination of cannabidiol and TNF-related apoptosis-inducing ligand (TRAIL) produces synergistic antitumor effects in vitro. However, this synergistic effect was not observed in normal colonic cells. The levels of ER stress-related proteins, including C/EBP homologous protein (CHOP) and phosphorylated protein kinase RNA-like ER kinase (PERK) were increased in treatment of cannabidiol. Cannabidiol enhanced significantly DR5 expression by ER stress. Knockdown of DR5 decreased the combined effect of cannabidiol and TRAIL. Additionally, the combination of TRAIL and cannabidiol decreased tumor growth in xenograft models. Our studies demonstrate that cannabidiol enhances TRAIL-induced apoptosis by upregulating DR5 and suggests that cannabidiol is a novel agent for increasing sensitivity to TRAIL.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 3. Graduate School > Graduate School > 1. Journal Articles
- 2. Clinical Science > Department of Colon and Rectal Surgery > 1. Journal Articles
- 2. Clinical Science > Department of Medical Oncology and Hematology > 1. Journal Articles
- 4. Research institute > Institute of Convergence New Drug Development > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.